AMPD2 and kidney disorder: Furthermore, AMPD2, the renal AMP deaminase isoform, would be a key target in the pathogenesis of AKI as its blockade would prevent both the early and late ATP depletion, and therefore it would be more beneficial to accelerate kidney disease post-AKI.